Celldex Therapeutics Inc. (NASDAQ:CLDX) options contracts experienced a new 3-month record for both call and put contracts where a total of 6,742 call and 4,844 put contracts were traded in the busy trading session. The contract spread yielded a 0.72 put/call ratio. Celldex Therapeutics, Inc. (NASDAQ:CLDX) shares after opening at $18.62 moved to $18.97 on last trade day and at the end of the day closed at $16.95. Company price to sales ratio in past twelve months was calculated as 193.41 and price to cash ratio as 10.05. Celldex Therapeutics, Inc. (NASDAQ:CLDX) showed a negative weekly performance of -21.24%.
Research analysts at Jefferies Group reduced their price objective on shares of Aegerion Pharmaceuticals (NASDAQ:AEGR) to $80.00 in a report released on Friday, Stock Ratings Network reports. The firm currently has a “buy” rating on the stock. Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) shares advanced 2.79% in last trading session and ended the day on $44.87. AEGR return on equity ratio is recorded as -53.80% and its return on assets is -45.10%. Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) yearly performance is 11.23%.
TherapeuticsMD Inc (NYSEMKT:TXMD) Insider John C.K. Iv Milligan sold 353,412 shares of TherapeuticsMD stock in a transaction that occurred on Wednesday, March 26th. The stock was sold at an average price of $6.70, for a total transaction of $2,367,860.40.TherapeuticsMD Inc (NYSEMKT:TXMD) shares moved down -0.83% in last trading session and was closed at $6.00 while trading in range of $5.21 – $6.12 – TherapeuticsMD Inc (NYSEMKT:TXMD) year to date (YTD) performance is 15.16%.
Shares of Newpark Resources (NYSE:NR) have earned a consensus recommendation of “Hold” from the eleven analysts that are covering the company, American Banking and Market News reports. Seven research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Newpark Resources Inc (NYSE:NR) weekly performance is -0.71%. On last trading day company shares ended up $11.18. Newpark Resources Inc (NYSE:NR) distance from 50-day simple moving average (SMA50) is -1.45%. Analysts mean target price for the company is $13.17.